Merck Animal Health Announces the European Approval of NOBILIS MULTRIVA™ REOm for Use in Chickens
New vaccine reduces viraemia and clinical signs of disease caused by avian reovirus, expanding NOBILIS MULTRIVA portfolio RAHWAY, N.J., March 27, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that the European Commission has […]